Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Double blind randomized study to evaluate the efficiency of intravenous ferric carboxymaltose in preventing anemia after cardiopulmonary bypass in children with congenital heart disease Doppelblind randomisierte Studie zur Evaluierung der Wirksamkeit der Gabe von Eisen(III)carboxymaltose zur Verhinderung von postoperativer Anämie nach Operation angeborener Herzfehler

Trial Profile

Double blind randomized study to evaluate the efficiency of intravenous ferric carboxymaltose in preventing anemia after cardiopulmonary bypass in children with congenital heart disease Doppelblind randomisierte Studie zur Evaluierung der Wirksamkeit der Gabe von Eisen(III)carboxymaltose zur Verhinderung von postoperativer Anämie nach Operation angeborener Herzfehler

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ferric carboxymaltose (Primary)
  • Indications Anaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top